Key facts
- It has raised $14.2M; the latest was Early Stage VC in May 2025.
- Notable investors include CAS Star, SDIC Unity Capital, 3E Bioventures Capital, Fortera Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Sipeng Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Sipeng Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sipeng Technology
Developer and provider of bio-based products designed for synthetic biology. The company develops synthetic biology technology and focuses on negative carbon new material, polymer monomers and a variety of high-value compounds, enabling clients with bio-based products.
- Sector
- Materials and Resources
- HQ
- Shanghai, China
- Founded
- 2022
- Website
- 4-life.com.cn/
- Ownership
- Privately Held (backing)
Sipeng Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sipeng Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sipeng Technology in its N-PORT filings yet. We sweep new filings monthly.